PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 133 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $151,038 | +2920.8% | 4,923 | +6377.6% | 0.00% | – |
Q4 2021 | $5,000 | -96.4% | 76 | -96.7% | 0.00% | – |
Q2 2021 | $140,000 | -13.6% | 2,315 | 0.0% | 0.00% | – |
Q1 2021 | $162,000 | 0.0% | 2,315 | -14.5% | 0.00% | – |
Q4 2020 | $162,000 | +33.9% | 2,709 | +34.8% | 0.00% | – |
Q3 2020 | $121,000 | +764.3% | 2,009 | +678.7% | 0.00% | – |
Q2 2020 | $14,000 | -93.2% | 258 | -95.2% | 0.00% | -100.0% |
Q1 2019 | $206,000 | -43.9% | 5,411 | -36.5% | 0.00% | -33.3% |
Q4 2018 | $367,000 | -45.2% | 8,522 | -60.4% | 0.00% | -57.1% |
Q1 2018 | $670,000 | +71.4% | 21,508 | +106.4% | 0.01% | +75.0% |
Q3 2017 | $391,000 | +299.0% | 10,423 | +244.1% | 0.00% | +300.0% |
Q4 2016 | $98,000 | -80.2% | 3,029 | -79.1% | 0.00% | -80.0% |
Q3 2016 | $496,000 | +103.3% | 14,486 | +215.1% | 0.01% | +66.7% |
Q1 2016 | $244,000 | -80.3% | 4,597 | -71.5% | 0.00% | -80.0% |
Q4 2015 | $1,240,000 | +123.0% | 16,152 | +19.4% | 0.02% | +87.5% |
Q3 2015 | $556,000 | -31.9% | 13,530 | +17.2% | 0.01% | -27.3% |
Q2 2015 | $816,000 | -41.5% | 11,540 | -26.4% | 0.01% | -50.0% |
Q1 2015 | $1,394,000 | +95.0% | 15,689 | +101.6% | 0.02% | +100.0% |
Q2 2014 | $715,000 | -26.7% | 7,781 | -44.2% | 0.01% | -31.2% |
Q1 2014 | $976,000 | +400.5% | 13,947 | +107.9% | 0.02% | +220.0% |
Q2 2013 | $195,000 | – | 6,710 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |